(Q43671243)

25 November 2017

title

Fluticasone propionate and budesonide do not influence bone metabolism in the long term treatment of asthma (English)

1 reference

25 November 2017

1 reference

fluticasone propionate

1 reference

Harmanci E

1

1 reference

25 November 2017

Colak O

2

1 reference

25 November 2017

Metintas M

3

1 reference

25 November 2017

Alatas O

4

1 reference

25 November 2017

Yurdasiper A

5

1 reference

25 November 2017

publication date

1 January 2001

1 reference

Allergologia et Immunopathologia

25 November 2017

published in

1 reference

25 November 2017

volume

29

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

22-27

1 reference

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Beclomethasone inhalation decreases serum osteocalcin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Bone turnover during high dose inhaled corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Bronchial reactivity to inhaled histamine: a method and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: A randomized, double-blind, parallel-group controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Is delayed introduction of inhaled corticosteroids harmful in patients with obstructive airways disease (asthma and COPD)? The Dutch CNSLD Study Group. The Dutch Chronic Nonspecific Lung Disease Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

A large volume spacer significantly reduces the effect of inhaled steroids on bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-0546%2801%2979011-8

7 January 2021

10.1016/S0301-0546(01)79011-8

Identifiers

DOI

1 reference

25 November 2017

1 reference